Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.

Thank you to our sponsors:
Athletic Greens – n
Belcampo – n
InsideTracker – n

Dr. Matthew Johnson Social Media:
Twitter: r
Instagram: r

Our Patreon page:
n

Supplements from Thorne:
n

Social:
Instagram – b
Twitter – b
Facebook – b
Website – m
Newsletter – k

Links:
Dr. Johnson’s Website at Johns Hopkins School of Medicine – n
Chris Letheby’s forthcoming book –

Timestamps:
00: 00: 00 Introducing Dr. Matthew Johnson
00: 02: 10 Supporting Sponsors
00: 06: 40 ‘Psychedelics’ Defined
00: 14: 09 Hallucinations, Synesthesia, Altered Space-Time Perception
00: 19: 56 Serotonin & Dopamine
00: 23: 50 Ketamine & Glutamate
00: 28: 00 An Example Psychedelic Experiment
00: 37: 30 ‘Letting Go’ with Psychedelics
00: 44: 10 Our Mind’s Eye
00: 48: 00 Redefining Your Sense of Self
00: 58: 56 Exporting Psychedelic Learnings to Daily Life
01: 04: 36 Flashbacks
01: 12: 10 Ayahuasca, & ASMR, Kundalini Breathing
01: 15: 54 MDMA, DMT
01: 26: 00 Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis
01: 38: 15 Micro-Dosing
01: 56: 45 Risks for Kids, Adolescents & Teenagers; Future Clinical Trials
02: 03: 40 Legal Status: Decriminalization vs. Legalization vs. Regulation
02: 18: 35 Psychedelics for Treating Concussion & Traumatic Brain Injury
02: 27: 45 Shifting Trends in Psychedelic Research, Academic Culture
02: 44: 23 Participating in a Clinical Trial, Online Survey Studies, Breathwork
02: 50: 38 Conclusions, Subscribing & Supporting the HLP, Supplements

Please note that The Huberman Lab Podcast is distinct from Dr. Huberman’s teaching and research roles at Stanford University School of Medicine. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Huberman Lab Podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.

Title Card Photo Credit: Mike Blabac – m

https://brain-therapy.com/dr-matthew-johnson-psychedelics-for-treating-mental-disorders-huberman-lab-podcast-38/

So here is an update finally! I hope you all enjoy it! Below you can find a list of the topics that I touch on.

Does the medication still work for me?
How do I deal with the nausea?
Do I take it every day?
Do I recommend concerta?
Concerta side effects for me now?
How do you get tested for ADHD?
-there are some online evaluations
-but if you would like to gain the benefits of a diagnosis go to a professional. You can visit your local behavior health practice and see a psychiatrist.
How have I been coping with ADHD?
Do I recommend taking medication?
How do I deal with feelings of inadequacy due to my ADHD and learning disability/ dealing with depression?
Getting my diagnosis as an adult and being in the workforce.
Personality changes.
Somethings I found to be helpful with taking my medication.
Learning disabilities vid




m
/> /
/>



Talky Beat by Twin Musicom is licensed under a Creative Commons Attribution 4.0 license. /

Source: t

Artist: g

Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology of MDMA, LSD, psilocybin and ayahuasca. Dr. Johnson shares the results of clinical trials in his laboratory that reveal the potential of these compounds for treating depression, addiction, eating disorders, ADHD and other mental disorders. Dr. Johnson explains how he conducts a typical psychedelic experiment at his lab, from start to finish. He also outlines the conditions necessary for optimal clinical results. He also explains the dangers, common myths, and pitfalls of psychedelic medicine. Dr. Johnson discusses flashbacks, the increased risks for certain age groups and people using psychedelics, and the constantly changing legal and pharmaceutical industry landscape around psychedelics. Dr. Johnson also discusses how scientific research on psychedelics will determine the future direction of psychiatric medicine. Johnson is one of a few researchers who pioneered clinical research on these powerful compounds. Johnson has unparalleled insight into the ways these compounds can be integrated into other psychiatric treatments. This allows for a change in one’s perception of self and reality.

We are grateful to our sponsors:
Athletic Greens –
Belcampo – n
InsideTracker –

Dr. Matthew Johnson Social Media
Twitter: r
Instagram: r

Our Patreon page
n

Supplements from Thorne
n

Social:
Instagram – b
Twitter – b
Facebook – b
Website – m
Newsletter – k

Links:
Website of Dr. Johnson at Johns Hopkins School of Medicine. n
Chris Letheby’s upcoming book

Timestamps:
00: 00: 00 Introducing Dr. Matthew Johnson
00: 02: 10 Supporting Sponsors
00: 06: 40 ‘Psychedelics’ Defined
00: 14: 09 Hallucinations, Synesthesia, Altered Space-Time Perception
00: 19: 56 Serotonin & Dopamine
00: 23: 50 Ketamine & Glutamate
00: 28: 00 An Example Psychedelic Experiment
00: 37: 30 ‘Letting Go’ with Psychedelics
00: 44: 10 Our Mind’s Eye
00: 48: 00 Redefining Your Sense of Self
00: 58: 56 Exporting Psychedelic Learnings to Daily Life
01: 04: 36 Flashbacks
01: 12: 10 Ayahuasca, & ASMR, Kundalini Breathing
01: 15: 54 MDMA, DMT
01: 26: 00 Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis
01: 38: 15 Micro-Dosing
01: 56: 45 Risks for Kids, Adolescents & Teenagers; Future Clinical Trials
02: 03: 40 Legal Status: Decriminalization vs. Legalization vs. Regulation
02: 18: 35 Psychedelics for Treating Concussion & Traumatic Brain Injury
02: 27: 45 Shifting Trends in Psychedelic Research, Academic Culture
02: 44: 23 Participating in a Clinical Trial, Online Survey Studies, Breathwork
02: 50: 38 Conclusions, Subscribing & Supporting the HLP, Supplements

The Huberman Lab Podcast does not include Dr. Huberman’s research and teaching roles at Stanford University School of Medicine. This podcast is not intended to replace medical advice. The Huberman Lab Podcast, its guests, and affiliates, assume no responsibility for the use of the information.

Photo credit for Title Card: Mike Blabac – m

http://adhdadulttreatment.com/dr-matthew-johnson-psychedelics-for-treating-mental-disorders-huberman-lab-podcast-38/

Attention deficit hyperactivity disorder (ADHD) is a commonly misunderstood mental health condition. This video explains ADHD and the symptoms (ADD and ADHD). The video also addresses the treatment options available to treat ADHD symptoms, including medication and psychotherapy. The video also touches on research that has highlighted the benefits of using video games to treat ADHD symptoms.

This video was created by McMaster students Abhitikuhad, Veronica Iskander and Sundas Ramzan in collaboration with McMaster Demystifying Medicine Program .
Subscribe to McMaster Demystifying medicine YouTube channel: e

This video is intended for educational purposes only. For information about your health, please consult your doctor.

Copyright McMaster University 2019

#DemystifyingMedicine, #MentalHealth
References:

Ramtekkar, U. P., Reiersen, A. M., Todorov, A. A., & Todd, R. D. (2010). Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. Journal of the American Academy of Child & Adolescent Psychiatry, 49(3), 217-228. Retrieved from /

Rucklidge, J. J. (2010). Gender differences in attention-deficit/hyperactivity disorder. Psychiatric Clinics, 33(2), 357-373. Retrieved from 2

Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012). Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. European child & adolescent psychiatry, 21(9), 477-492. doi: 10. 1007/s00787-012-0286-5

Centres for Disease Control and Prevention. (2019). What is ADHD? Retrieved from

Sprich, S. E., Burbridge, J., Lerner, J. A., & Safren, S. A. (2015). Cognitive-behavioral treatment for ADHD in adolescents: Clinical considerations and a series of cases. Cognitive and behavioral practice, 22(2), 116-126. doi: 10.1016/j.cbpra.2015. 01.001

Geffen, J., & Forster, K. (2018). A clinical perspective on adult ADHD treatment. Therapeutic advances in psychopharmacology, 8(1), 25-32. doi: 10. 1177/2045125317734977

Wilens, T. E., & Spencer, T. J. (2010). Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgraduate medicine, 122(5), 97-109. doi: 10.3810/pgm.2010.09. 2206

National Institute for Mental Health. (2019). Attention-Deficit/Hyperactivity Disorder. (2019). Retrieved from.

Bailey, E. (2019). Adderall vs. Ritalin - An ADHD Medication Comparison. ADDitude. Retrieved from /

Sigler, U. (2019). ADHD Looks Different in Women. Here are the reasons and how to do it. ADDitude. Retrieved from /

Storebo, O. J., Pedersen, N., Ramstad, E., Kielsholm, M. L., Nielsen, S. S., Krogh, H. B., ... Gluud, C. (2018, May 9). Assessment of adverse events in non-randomised studies involving methylphenidate in attention deficit hyperactivity disorder (ADHD), in children and teens Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. 2

Faraone, S. V. (2018). The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neuroscience & Biobehavioral Reviews, 87, 255-270. 1

Waite, R. (2010). ADHD in Women: This is not an excuse, but an explanation. Perspectives in Psychiatric Care, 46(3), 182-196. x

Knouse, L. E., & Safren, S. A. (2010). Current status of cognitive behavioral therapy (CBT) for adult attention deficit hyperactivity disorder. Psychiatric Clinics of North America. W.B. Saunders. 1

Parekh, R. (2017). What is ADHD? American Psychiatry Association. Retrieved from d

Davis, N. O., Bower, J., & Kollins, S. H. (2018). A proof-of-concept study on a digital intervention for ADHD in children at home. PLoS ONE, 13(1). 9